Stockscreener 앱 받기
0.2757
6.54%
-0.0193
시간 외 거래:
.29
0.0143
+5.19%
Vincerx Pharma Inc 주식(VINC)의 최신 뉴스
Leerink Partnrs Weighs in on Vincerx Pharma FY2024 Earnings - Defense World
ARMISTICE CAPITAL, LLC Expands Stake in Vincerx Pharma Inc - GuruFocus.com
Prosight Management, LP Reduces Stake in Vincerx Pharma Inc - GuruFocus.com
Vincerx Pharma Inc (VINC) Quarterly 10-Q Report - Quartzy
Vincerx Pharma Reports Q3 2024 Financial Results - TipRanks
Vincerx Pharma Inc reports results for the quarter ended September 30Earnings Summary - XM
Vincerx Pharma Reports Third Quarter 2024 Financial Results - GlobeNewswire
Vincerx Pharma Reports Complete Responses in VIP943 Trial, Narrows Q3 Loss to $0.17/Share | VINC Stock News - StockTitan
VINC stock touches 52-week low at $0.32 amid market challenges - Investing.com Canada
SEC Form PRE 14A filed by Vincerx Pharma Inc. - Quantisnow
VINC Stock on the Rise: A Promising Investment - The InvestChronicle
Should investors be concerned about Vincerx Pharma Inc (VINC)? - US Post News
Financial Health Check: Examining Vincerx Pharma Inc (VINC)’s Key Ratios - The Dwinnex
What Makes Vincerx Pharma (VINC) a New Buy Stock - Yahoo Finance
Check Out Vincerx Pharma Inc (VINC)’s Trade Data Rather Than the Analysts’ Views - SETE News
Taking a Closer Look At Vincerx Pharma Inc (VINC) Following Its Recent Trade - Knox Daily
VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges By Investing.com - Investing.com South Africa
VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges - Investing.com
Wall Street Analyst Initiated Vincerx Pharma Inc [VINC]. What else is Wall St. saying - The DBT News
Vincerx Pharma Inc (VINC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Leerink Partners Cuts Vincerx Pharma (NASDAQ:VINC) Price Target to $2.00 - Defense World
Vincerx reports two complete responses in VIP943 study By Investing.com - Investing.com Australia
VINC’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Vincerx stock tumbles 20% on corporate updates - MSN
Vincerx stock tumbles 20% on corporate updates (NASDAQ:VINC) - Seeking Alpha
Leerink cuts Vincerx Pharma stock target on pipeline update By Investing.com - Investing.com UK
Financial Fitness Check: Examining Vincerx Pharma Inc (VINC)’s Key Ratios - The Dwinnex
Vincerx reports two complete responses in VIP943 study - Investing.com
Vincerx Reports Positive Initial Clinical Data from Ongoing - GlobeNewswire
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates - StockTitan
Why Is Cancer Focused Penny Stock Vincerx Pharma Trading Higher Today? - MSN
Vincerx Pharma (NASDAQ:VINC) Trading Down 2.1% - Defense World
A better buy-in window may exist right now for Vincerx Pharma Inc (VINC) - SETE News
Investing in Vincerx Pharma Inc (VINC) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely - Simply Wall St
Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky - Yahoo Finance
Vanguard Group Inc. Has $3.38 Million Position in Vincerx Pharma, Inc. (NASDAQ:VINC) - Defense World
Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval - TipRanks
VINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024 - MSN
Vincerx Pharma Reports Second Quarter 2024 Financial Results - GlobeNewswire
Acadian Asset Management LLC Sells 36,571 Shares of Vincerx Pharma, Inc. (NASDAQ:VINC) - Defense World
Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Decreases By 31.7% - Defense World
How should investors view Vincerx Pharma Inc (VINC)? – US Post News - US Post News
Vincerx Pharma Inc (VINC) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Down 29.3% in June - Defense World
Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts? - Yahoo Finance
Vincerx Pharma Inc Inc. (VINC) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade - MSN
Vincerx Pharma (NASDAQ:VINC) Trading Down 7.1% - Defense World
Balance Sheet Insights: Vincerx Pharma Inc (VINC)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Investing News Network
Vincerx Pharma to Participate in the Jefferies Virtual Healthcare Conference - The Globe and Mail
Vincerx Pharma, Inc. (NASDAQ:VINC) Short Interest Update - Defense World
Vincerx Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual ... - The Globe and Mail
Vincerx Pharma Reports First Quarter 2021 Financial Results and Provides a Corporate Update - The Globe and Mail
Vincerx Pharma Announces Completion of Public Warrant Redemption - The Globe and Mail
Market Recap Check: Vincerx Pharma Inc (VINC)'s Negative Finish at 0.68, Up/Down -2.81 – DWinneX - The Dwinnex
Is Vincerx Pharma Inc (VINC) a threat to investors? – US Post News - US Post News
Vincerx Pharma (VINC) Price Target Increased by 10.53% to 7.14 - MSN
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday? - MSN
3.66%
1.11%
자본화:
|
볼륨(24시간):